Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy.
Yaga M, Hasegawa K, Ikeda S, Matsubara M, Hiroshima T, Kimura T, Shirai Y, Tansri W, Uehara H, Tachikawa M, Okairi Y, Sone M, Mori H, Kogue Y, Akamine H, Okuzaki D, Kawagishi K, Kawanaka S, Yamato H, Takeuchi Y, Okura E, Kanzaki R, Okami J, Nakamichi I, Nakane S, Kobayashi A, Iwazawa T, Tokunaga T, Yokouchi H, Yano Y, Uchida J, Mori M, Komuta K, Tachi T, Kuroda H, Kijima N, Kishima H, Ichii M, Futami S, Naito Y, Shiroyama T, Miyake K, Koyama S, Hirata H, Takeda Y, Funaki S, Shintani Y, Kumanogoh A, Hosen N. Yaga M, et al. Among authors: kuroda h. Sci Rep. 2024 Aug 2;14(1):17917. doi: 10.1038/s41598-024-68779-9. Sci Rep. 2024. PMID: 39095551 Free PMC article.
Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy.
Nakagawa T, Kijima N, Hasegawa K, Ikeda S, Yaga M, Wibowo T, Tachi T, Kuroda H, Hirayama R, Okita Y, Kinoshita M, Kagawa N, Kanemura Y, Hosen N, Kishima H. Nakagawa T, et al. Among authors: kuroda h. Neurooncol Adv. 2022 Nov 15;5(1):vdac177. doi: 10.1093/noajnl/vdac177. eCollection 2023 Jan-Dec. Neurooncol Adv. 2022. PMID: 36601313 Free PMC article.
Awake surgery for a deaf patient using sign language: A case report.
Yamamoto A, Kijima N, Utsugi R, Mrakami K, Kuroda H, Tachi T, Hirayama R, Okita Y, Kagawa N, Kishima H. Yamamoto A, et al. Among authors: kuroda h. Surg Neurol Int. 2024 May 24;15:167. doi: 10.25259/SNI_52_2024. eCollection 2024. Surg Neurol Int. 2024. PMID: 38840599 Free PMC article.
Calvarial Thickening in Tuberous Sclerosis Complex.
Kuroda H, Khoo HM, Fujita Y, Tominaga K, Kagitani-Shimono K, Hosomi K, Tani N, Oshino S, Wataya-Kaneda M, Kishima H. Kuroda H, et al. World Neurosurg. 2024 Dec;192:e460-e467. doi: 10.1016/j.wneu.2024.09.130. Epub 2024 Oct 22. World Neurosurg. 2024. PMID: 39366482 Free article.
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model.
Tachi T, Kijima N, Kuroda H, Ikeda S, Murakami K, Nakagawa T, Yaga M, Nakagawa K, Utsugi R, Hirayama R, Okita Y, Kagawa N, Kishima H, Imai C, Hosen N. Tachi T, et al. Among authors: kuroda h. Cancer Immunol Immunother. 2024 Oct 5;73(12):256. doi: 10.1007/s00262-024-03808-0. Cancer Immunol Immunother. 2024. PMID: 39367952 Free PMC article.
Dynamic susceptibility contrast‑enhanced perfusion magnetic resonance imaging parameters for predicting MGMT promoter methylation and prognostic value in newly diagnosed patients with glioblastoma.
Chida D, Okita Y, Utsugi R, Kuroda H, Hirayama R, Kijima N, Arisawa A, Kagawa N, Kanemura Y, Yoshimura S, Tomiyama N, Kishima H. Chida D, et al. Among authors: kuroda h. Oncol Lett. 2024 Oct 14;28(6):610. doi: 10.3892/ol.2024.14741. eCollection 2024 Dec. Oncol Lett. 2024. PMID: 39493435 Free PMC article.
1,307 results